Results 61 to 70 of about 5,601,796 (250)
Following oral administration, gastric emptying is often a rate-limiting step in the absorption of drugs and is dependent on both physiological and pharmaceutical factors. To guide translation into humans, small animal imaging during pre-clinical studies
Noemí Gómez-Lado +7 more
doaj +1 more source
Hollow cuprous oxide (H‐Cu2O) nanozymes feature enlarged catalytic surfaces for superior reactive oxygen species (ROS) scavenging. By efficiently neutralizing mucosal ROS, H‐Cu2O directly suppresses the TXNIP/NLRP3 inflammasome axis and restores intestinal epithelial barrier integrity.
Guangzhao Wang +7 more
wiley +1 more source
Oral drug delivery remains the most popular and convenient way of administering drugs in comparison with the other routes. Advantages include their effectiveness, convenience, less expensive, and non-invasiveness.
Muhamad, Haja +4 more
core +1 more source
Caracterização e estudos das propriedades no estado sólido do cloridrato de venlafaxina [PDF]
Tese (doutorado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Programa de Pós-Graduação em Farmácia, Florianópolis, 2013.O cloridrato de venlafaxina (VEN) é um inibidor da recaptação da serotonina e norepinefrina eficaz no ...
Bernardi, Larissa Sakis
core
The pharmaceutical development process starts with patient populations and their unmet therapeutic needs. Traditional pharmaceutical manufacturing of solid oral dosage forms is based on the strategy of one-size-fits-all.
Paulsson, Mattias, +5 more
core
Biowaiver monographs for immediate release solid oral dosage forms: Aciclovir [PDF]
Literature data relevant to the decision to allow a waiver of in vivo bioequivalence (BE) testing (biowaiver) for the approval of immediate release (IR) solid oral dosage forms containing aciclovir are reviewed.
Arnal, J. +10 more
core +1 more source
Suitability of the z-Factor for Dissolution Simulation of Solid Oral Dosage Forms
S.2735-2745Parameterization of dissolution profiles for subsequent use in in silico modeling and simulation is a crucial element for the success of extrapolating in vitro to in vivo release from solid oral dosage forms.
Hofsäss, M.A., Dressman, J.
core +1 more source
This study reports D34 as the first PROTAC degrader that targets the 3C protease of picornaviruses. D34 effectively degrades EV71 3C protease via the ubiquitin‐proteasome pathway. More importantly, D34 exhibits a high resistance barrier and shows broad‐spectrum antiviral activity against multiple picornaviruses, highlighting its potential as a novel ...
Weilong Deng +9 more
wiley +1 more source
The potential of three-dimensional printing for pediatric oral solid dosage forms
Pediatric patients often require individualized dosing of medicine due to their unique pharmacokinetic and developmental characteristics. Current methods for tailoring the dose of pediatric medications, such as tablet splitting or compounding liquid ...
Kreft Klemen +2 more
doaj +1 more source
This study unveils a novel antibacterial mechanism against MRSA, in which the compound Py‐27 selectively targets and inhibits aspartate transcarbamoylase (ATCase), a key enzyme in pyrimidine synthesis. This inhibition disrupts DNA replication, induces oxidative damage, leading to potent bactericidal activity.
Xiaorong Yang +11 more
wiley +1 more source

